Skip to main content
Clinical Trials/NL-OMON55598
NL-OMON55598
Recruiting
Not Applicable

A prospective study to assess the efficacy and safety of the BlueWind RENOVA iStim* System for the treatment of patients diagnosed with overactive bladder (OASIS - OverActive bladder StImulation System study) - BlueWind RENOVA iStim* System for the treatment of OAB

BlueWind Medical Ltd.0 sites25 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Overactive bladder
Sponsor
BlueWind Medical Ltd.
Enrollment
25
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 2 \- Female aged 18 or greater (21 or greater in the US), with no plans to
  • become pregnant
  • during the trial; if of bearing potential, negative pregnancy test and
  • if sexually active, using
  • acceptable contraception.
  • 4 \- Diagnosis of UUI demonstrated on a 7\-consecutive days voiding diary
  • a minimum of nine (9\) leaking episodes associated with urgency with at
  • least one episode per
  • day for 5 days.
  • 5 \- More than or equal to 6 months history of UUI diagnosis

Exclusion Criteria

  • 1 \- Previous participation in another study with any investigational drug or
  • within the past 90 days
  • 5 \- Any significant medical condition that is likely to interfere with study
  • procedures,
  • device operation, or likely to confound evaluation of study endpoints
  • 19 \- More than minimal level of stress incontinence or mixed incontinence
  • with stress
  • component likely to confound study outcome, based on a 7\-day voiding
  • diary or medical history,or when stress incontinence score in the MESA
  • incontinence questionnaire is higher than the urgency incontinence score

Outcomes

Primary Outcomes

Not specified

Similar Trials